NUTX

SEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 4

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,371

F3 · shares: Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations.

SEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 2

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387

F2 · shares: Of the 111 shares issued subsequent to vesting, 24 shares were sold to cover tax withholding obligations.

SEC source: 0001486189-25-000013 · primary_doc.xml · nonDerivative · entry 2

Chang Michael L. · CIK 0001919832 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (3)

Disclosed balance after: 81,041

F2 · shares: Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations.

F3 · ownership.direct: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 80,057 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.

SEC source: 0001486189-25-000012 · primary_doc.xml · nonDerivative · entry 2

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (4)

Disclosed balance after: 1,837,879

F2 · shares: Of the 5,000 shares issued subsequent to vesting, 895 shares were sold to cover tax withholding obligations.

F4 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,813,965 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

F4 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,813,965 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

SEC source: 0001486189-25-000011 · primary_doc.xml · nonDerivative · entry 2

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,422

F2 · shares: Of the shares 3,776 issued subsequent to vesting, 1,072 shares were sold to cover tax withholding obligations.

SEC source: 0001486189-25-000017 · primary_doc.xml · derivative · entry 4

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 3,500 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 3,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F2 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 3,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000010 · primary_doc.xml · derivative · entry 3

Luqman Elisa V · CIK 0001486189 · Chief Legal Officer - SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,500 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F4 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000016 · primary_doc.xml · derivative · entry 3

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 406

Underlying: Common Stock · 120 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 120 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F3 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 120 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000014 · primary_doc.xml · derivative · entry 5

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,500 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F4 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000013 · primary_doc.xml · derivative · entry 3

Chang Michael L. · CIK 0001919832 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,500 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F4 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000012 · primary_doc.xml · derivative · entry 3

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted [Col x] RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F3 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted [Col x] RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000011 · primary_doc.xml · derivative · entry 3

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,102

Underlying: Common Stock · 7,551 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted [Col x] RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F3 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted [Col x] RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000015 · primary_doc.xml · derivative · entry 3

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,200

Underlying: Common Stock · 5,950 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

F3 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

SEC source: 0001486189-25-000015 · primary_doc.xml · nonDerivative · entry 1

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000017 · primary_doc.xml · nonDerivative · entry 2

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000017 · primary_doc.xml · nonDerivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000010 · primary_doc.xml · nonDerivative · entry 1

Luqman Elisa V · CIK 0001486189 · Chief Legal Officer - SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000016 · primary_doc.xml · nonDerivative · entry 1

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,026

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 3

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,637

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 1

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 411

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000013 · primary_doc.xml · nonDerivative · entry 1

Chang Michael L. · CIK 0001919832 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (3)

Disclosed balance after: 81,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · ownership.direct: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 80,057 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.

SEC source: 0001486189-25-000012 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (4)

Disclosed balance after: 1,838,774

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000011 · primary_doc.xml · nonDerivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001486189-25-000001 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 1,833,774

F1 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,809,860 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

SEC source: 0001486189-24-000043 · primary_doc.xml · nonDerivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,277

SEC source: 0001486189-24-000042 · primary_doc.xml · nonDerivative · entry 2

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,808

F1 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship.

SEC source: 0001486189-24-000042 · primary_doc.xml · nonDerivative · entry 1

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,233

F1 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship.

SEC source: 0001486189-24-000041 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(2)

Disclosed balance after: 1,828,774

F1 · price: As per the Agreement and Plan of Merger (the Merger Agreement), as described in the Issuers definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received an additional 22,709 shares of Common Stock of the Issuer for owners pro rata share of eligible Under Construction Hospital as defined in the Merger Agreement, pursuant to the share calculation defined in the Merger Agreement.

F2 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,804,860 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

SEC source: 0001486189-24-000033 · primary_doc.xml · derivative · entry 1

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,750

Underlying: Common Stock · 63,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. DeTillio, dated June 28, 2024, the 63,750 RSUs granted to Mr. DeTillio will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. DeTillio, dated June 28, 2024, the 63,750 RSUs granted to Mr. DeTillio will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000032 · primary_doc.xml · derivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,301

Underlying: Common Stock · 45,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated June 28, 2024, the 45,000 RSUs granted to Mr. Bates will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated June 28, 2024, the 45,000 RSUs granted to Mr. Bates will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000036 · primary_doc.xml · derivative · entry 1

Luqman Elisa V · CIK 0001486189 · Chief Legal Officer-SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Luqman, dated June 28, 2024, the 37,500 RSUs granted to Ms. Luqman will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Luqman, dated June 28, 2024, the 37,500 RSUs granted to Ms. Luqman will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000035 · primary_doc.xml · derivative · entry 1

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,601

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated June 28, 2024, the 37,500 RSUs granted to Ms. Montgomery will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated June 28, 2024, the 37,500 RSUs granted to Ms. Montgomery will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000031 · primary_doc.xml · derivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,265

Underlying: Common Stock · 113,265 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Hosseinion dated June 28, 2024, the 113,265 RSUs granted to Dr. Hosseinion will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Hosseinion dated June 28, 2024, the 113,265 RSUs granted to Dr. Hosseinion will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000034 · primary_doc.xml · derivative · entry 1

Chang Michael L. · CIK 0001919832 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Chang, dated June 28, 2024, the 37,500 RSUs granted to Dr. Change will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Chang, dated June 28, 2024, the 37,500 RSUs granted to Dr. Change will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting

SEC source: 0001486189-24-000030 · primary_doc.xml · derivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,265

Underlying: Common Stock · 113,265 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Hosseinion dated June 28, 2024, the 113,265 RSUs granted to Dr. Hosseinion will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Hosseinion dated June 28, 2024, the 113,265 RSUs granted to Dr. Hosseinion will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · balance_after: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000029 · primary_doc.xml · derivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Vo, dated June 28, 2024, the 150,000 RSUs granted to Dr. Vo will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Vo, dated June 28, 2024, the 150,000 RSUs granted to Dr. Vo will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000028 · primary_doc.xml · nonDerivative · entry 1

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,333

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.5352 to $0.5353 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F2 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship.

SEC source: 0001486189-24-000027 · primary_doc.xml · nonDerivative · entry 4

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(2)

Disclosed balance after: 18,060,663

F2 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 17,821,518 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 239,145 of the securities of the registrant reported herein.

SEC source: 0001486189-24-000027 · primary_doc.xml · nonDerivative · entry 3

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(2)

Disclosed balance after: 18,057,677

F2 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 17,821,518 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 239,145 of the securities of the registrant reported herein.

SEC source: 0001486189-24-000027 · primary_doc.xml · nonDerivative · entry 2

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(2)

Disclosed balance after: 18,053,909

F2 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 17,821,518 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 239,145 of the securities of the registrant reported herein.

SEC source: 0001486189-24-000027 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(2)

Disclosed balance after: 18,005,515

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.0.6399 to $0.6980, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F2 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 17,821,518 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 239,145 of the securities of the registrant reported herein.

SEC source: 0001486189-24-000020 · primary_doc.xml · derivative · entry 2

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,505

Underlying: Common Stock · 49,505 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F3 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025

F3 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025

F2 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000020 · primary_doc.xml · nonDerivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on March 1, 2024 through the issuance of shares of Common Stock.

F2 · price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000019 · primary_doc.xml · derivative · entry 2

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,501

Underlying: Common Stock · 16,502 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F3 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F3 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F2 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-24-000019 · primary_doc.xml · nonDerivative · entry 1

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on March 1, 2024 through the issuance of shares of Common Stock.

F2 · price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001486189-23-000042 · primary_doc.xml · nonDerivative · entry 2

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (3)

Disclosed balance after: 269,822,776

F2 · price: . The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $00.2221 to $0.2370, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (2) to this Form 4.

F3 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 2,500,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000042 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (3)

Disclosed balance after: 269,547,576

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.2172 to $0.2395, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F3 · balance_after: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 2,500,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000041 · primary_doc.xml · nonDerivative · entry 1

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.2269 to $0.2491 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F2 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship.

SEC source: 0001486189-23-000036 · primary_doc.xml · derivative · entry 3

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,795

Underlying: Common Stock · 10,795 shares

Expires 2024-12-31

SEC source: 0001486189-23-000036 · primary_doc.xml · derivative · entry 2

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,609,779

Underlying: Common Stock · 50,000 shares

Expires 2030-01-27

F1 · price: The options were granted pursuant to the Issuers 2019 Omnibus Equity Incentive Plan and Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan.

F1 · balance_after: The options were granted pursuant to the Issuers 2019 Omnibus Equity Incentive Plan and Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan.